127 related articles for article (PubMed ID: 34420860)
61. [Present and future in brachytherapy--from the discovery of radium to the 21st century].
Inoue T; Inoue T
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1254-60. PubMed ID: 10478177
[TBL] [Abstract][Full Text] [Related]
62. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
[TBL] [Abstract][Full Text] [Related]
63. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML
Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275
[TBL] [Abstract][Full Text] [Related]
64. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
65. Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based Study.
Parry MG; Nossiter J; Sujenthiran A; Cowling TE; Patel RN; Morris M; Berry B; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1219-1229. PubMed ID: 33279595
[TBL] [Abstract][Full Text] [Related]
66. A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer.
King MT; Yang DD; Muralidhar V; Mahal B; Butler S; Devlin PM; Lee LJ; Mouw KW; Martin NM; D'Amico AV; Nguyen PL; Orio PF
Brachytherapy; 2019; 18(2):186-191. PubMed ID: 30638912
[TBL] [Abstract][Full Text] [Related]
67. Fractionated high dose rate versus low dose rate regimens for intracavitary brachytherapy of the cervix. I. General considerations based on radiobiology.
Brenner DJ; Hall EJ
Br J Radiol; 1991 Feb; 64(758):133-41. PubMed ID: 2004204
[TBL] [Abstract][Full Text] [Related]
68. The trail of the development of high-dose-rate brachytherapy for cervical cancer in Japan.
Inoue T
Jpn J Clin Oncol; 2003 Jul; 33(7):327-30. PubMed ID: 12949057
[TBL] [Abstract][Full Text] [Related]
69. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
[TBL] [Abstract][Full Text] [Related]
70. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells.
Orton CG
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):183-9. PubMed ID: 11163513
[TBL] [Abstract][Full Text] [Related]
71. Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer.
Yang R; Zhao N; Liao A; Wang H; Qu A
Med Dosim; 2016; 41(3):236-41. PubMed ID: 27400663
[TBL] [Abstract][Full Text] [Related]
72. Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experience.
Ogorodniitchouk O; Aunier J; Bousarsar A; Lahmamssi C; Sotton S; Ouaz H; Moreno-Acosta P; Moslemi D; Molekzadehmoghani M; Langrand-Escure J; Magne N; Vallard A
Cancer Radiother; 2021 Jul; 25(5):463-468. PubMed ID: 34023215
[TBL] [Abstract][Full Text] [Related]
73. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model.
Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R
Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547
[TBL] [Abstract][Full Text] [Related]
74. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
Khor TH; Tuan JK; Hee SW; Tham IW
Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
[TBL] [Abstract][Full Text] [Related]
75. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
Lin L; Patel RR; Thomadsen BR; Henderson DL
Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
[TBL] [Abstract][Full Text] [Related]
76. Clinical implementation, logistics and workflow guide for MRI image based interstitial HDR brachytherapy for gynecological cancers.
Zhang H; Donnelly ED; Strauss JB; Kang Z; Gopalakrishnan M; Lee PC; Khelashvili G; Nair CK; Lee BH; Sathiaseelan V
J Appl Clin Med Phys; 2019 Nov; 20(11):37-49. PubMed ID: 31600015
[TBL] [Abstract][Full Text] [Related]
77. High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma - a radiobiological study.
Petera J; Matula P; Paluska P; Sirak I; Macingova Z; Kasaova L; Frgala T; Hodek M; Vosmik M
Neoplasma; 2009; 56(2):163-8. PubMed ID: 19239332
[TBL] [Abstract][Full Text] [Related]
78. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka University Hospital.
Teshima T; Inoue T; Ikeda H; Miyata Y; Nishiyama K; Inoue T; Murayama S; Yamasaki H; Kozuka T
Cancer; 1993 Oct; 72(8):2409-14. PubMed ID: 8402457
[TBL] [Abstract][Full Text] [Related]
79. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
80. Intracavitary radiation in the treatment of advanced esophageal carcinoma: a comparison of high dose rate vs. low dose rate brachytherapy.
Harvey JC; Fleischman EH; Bellotti JE; Kagan AR
J Surg Oncol; 1993 Feb; 52(2):101-4. PubMed ID: 7682263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
